NASDAQ:GH Guardant Health (GH) Stock Price, News & Analysis $154.86 +0.08 (+0.05%) Closing price 04:00 PM EasternExtended Trading$154.95 +0.09 (+0.06%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Guardant Health Stock (NASDAQ:GH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Guardant Health alerts:Sign Up Key Stats Today's Range$153.05▼$159.1150-Day Range$150.87▼$187.2252-Week Range$74.55▼$191.05Volume3.33 million shsAverage Volume2.21 million shsMarket Capitalization$20.95 billionP/E RatioN/ADividend YieldN/APrice Target$190.88Consensus RatingModerate Buy Company Overview Guardant Health is a precision oncology company that develops blood- and tissue-based tests to help guide cancer care. Founded in 2012 by Helmy Eltoukhy and AmirAli Talasaz, the company focuses on using genomic information to support cancer detection, treatment selection and disease monitoring. Its products include Guardant360 tests, which analyze tumor-related genetic changes to help inform treatment decisions, and Guardant Reveal, which is designed to detect residual or recurring cancer after treatment. Guardant Shield is a blood-based colorectal cancer screening test for eligible adults at average risk. The company also provides genomic testing and data services to pharmaceutical companies developing cancer therapies. Guardant Health serves patients and healthcare providers primarily in the United States, and its products and services are also available in certain international markets. Its work combines diagnostic testing with genomic data and analytics to support clinical care and cancer research.AI Generated. May Contain Errors. Read More Guardant Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks76th Percentile Overall ScoreGH MarketRank™: 3.80234833659 of 5 starsGuardant Health scored higher than 76% of companies evaluated by MarketBeat, and ranked 178th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingGuardant Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.96, and is based on 1 strong buy rating, 24 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialGuardant Health has a consensus price target of $190.88, representing about 23.3% upside from its current price of $154.86.Amount of Analyst CoverageGuardant Health has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Guardant Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Guardant Health are expected to grow in the coming year, from ($3.08) to ($2.01) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Guardant Health is -42.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Guardant Health is -42.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted7.45% of the float of Guardant Health has been sold short.Short Interest Ratio / Days to CoverGuardant Health has a short interest ratio ("days to cover") of 5.38.Change versus previous monthShort interest in Guardant Health has recently decreased by 19.16%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuardant Health does not currently pay a dividend.Dividend GrowthGuardant Health does not have a long track record of dividend growth. News and Social Media3.3 / 5News Sentiment0.33 News SentimentGuardant Health has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Guardant Health this week, compared to 7 articles on an average week.Search Interest17 people have searched for GH on MarketBeat in the last 30 days. This is an increase of 6% compared to the previous 30 days.MarketBeat Follows11 people have added Guardant Health to their MarketBeat watchlist in the last 30 days. This is an increase of 38% compared to the previous 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $16,752,081.00 in company stock.Percentage Held by Insiders5.60% of the stock of Guardant Health is held by insiders.Percentage Held by Institutions92.60% of the stock of Guardant Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Guardant Health's insider trading history. Receive GH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardant Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GH Stock News HeadlinesGuardant Health prices $500M convertible notes offeringNovember 12 at 7:04 AM | seekingalpha.comGuardant Health (NASDAQ:GH) Stock Price Target Cut by Piper SandlerNovember 12 at 2:13 AM | americanbankingnews.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 12 at 1:00 AM | Weiss Ratings (Ad)Guardant Health Prices $500 Million Convertible Senior Notes OfferingNovember 12 at 1:09 AM | businesswire.comStifel Nicolaus Remains a Buy on Guardant Health (GH)November 11 at 8:47 PM | theglobeandmail.comGuardant Health (NASDAQ:GH) Director Musa Tariq Sells 116 Shares of Company StockOctober 20, 2026 | insidertrades.comThe AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning (GH)AI-driven "biointelligence" is reshaping healthcare investing, with Guardant Health, Illumina, Eli Lilly and Moderna emerging as key stocks as data-driven testing, sequencing and therapies compound.October 19, 2026 | marketbeat.comInsider Selling: Guardant Health (NASDAQ:GH) Director Sells 69 Shares of Company StockOctober 16, 2026 | insidertrades.comSee More Headlines GH Stock Analysis - Frequently Asked Questions How have GH shares performed this year? Guardant Health's stock was trading at $102.14 on January 1st, 2026. Since then, GH shares have increased by 51.6% and is now trading at $154.86. How were Guardant Health's earnings last quarter? Guardant Health, Inc. (NASDAQ:GH) released its quarterly earnings results on Thursday, November, 5th. The company reported ($0.29) EPS for the quarter, beating analysts' consensus estimates of ($0.75) by $0.46. The company's revenue for the quarter was up 36.1% on a year-over-year basis. Read the conference call transcript. When did Guardant Health IPO? Guardant Health (GH) raised $200 million in an initial public offering (IPO) on Thursday, October 4th 2018. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. Who are Guardant Health's major shareholders? Top institutional investors of Guardant Health include William Blair Investment Management LLC (0.70%), Allspring Global Investments Holdings LLC (0.54%), Stephens Investment Management Group LLC (0.29%) and First Trust Advisors LP (0.25%). Insiders that own company stock include Helmy Eltoukhy, Darya Chudova, Chris Freeman, Michael Brian Bell, Amirali Talasaz, John G Saia, Terilyn J Monroe, Myrtle S Potter, Kumud Kalia, Musa Tariq, Meghan V Joyce, Steve E Krognes, Medina Manuel Hidalgo, Ian T Clark and Alex M Azar II. View institutional ownership trends. How do I buy shares of Guardant Health? Shares of GH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guardant Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardant Health investors own include NVIDIA (NVDA), Shopify (SHOP), Trade Desk (TTD), Advanced Micro Devices (AMD), Micron Technology (MU), Tesla (TSLA) and Twilio (TWLO). Company Calendar Last Earnings11/05/2026Today11/12/2026Jefferies Global Healthcare Conference11/18/202638th Annual Healthcare Conference12/01/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 GH's financial health is in the Green zone, according to TradeSmith. GH has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:GH CIK1576280 Webwww.guardanthealth.com Phone(855) 698-8887Fax888-974-4258Employees2,506Year Founded2012Price Target and Rating Average Price Target for Guardant Health$190.88 High Price Target$225.00 Low Price Target$120.00 Potential Upside/Downside+23.3%Consensus RatingModerate Buy Rating Score (0-4)2.96 Research Coverage26 Analysts Profitability EPS (Trailing Twelve Months)($3.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$416.28 million Net Margins-37.93% Pretax Margin-37.99% Return on EquityN/A Return on Assets-25.03% Debt Debt-to-Equity RatioN/A Current Ratio3.60 Quick Ratio3.35 Sales & Book Value Annual Sales$982.02 million Price / Sales21.33 Cash FlowN/A Price / Cash FlowN/A Book Value($2.04) per share Price / Book-75.91Miscellaneous Outstanding Shares135,290,000Free Float127,710,000Market Cap$20.95 billion OptionableOptionable Beta1.67 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:GH) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredElon wants to move AI off the planet. Amazon isn't ready.What if the next AI race isn't on Earth? Tim Bohen's Mission X presentation explores Elon Musk's idea of movin...StocksToTrade | SponsoredProfessor Who Lectured at Harvard Warns: Sell These 10 Stocks Before Dec. 10Joel Litman, a professor who has lectured at Harvard and Wharton, is warning of a $33 trillion grid crisis tha...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
